IDDF2024-ABS-0267 Continued treatment of early nonresponders or partial virologic responders with bulevirtide monotherapy in patients with chronic hepatitis delta through week 96 leads to improvement in virologic and biochemical responses

التفاصيل البيبلوغرافية
العنوان: IDDF2024-ABS-0267 Continued treatment of early nonresponders or partial virologic responders with bulevirtide monotherapy in patients with chronic hepatitis delta through week 96 leads to improvement in virologic and biochemical responses
المؤلفون: Yu, Jacques, Lampertico, Pietro, Wedemeyer, Heiner, Brunetto, Maurizia, Bogomolov, Pavel, Stepanova, Tatyana, Ciesek, Sandra, Berger, Annemarie, Manuilov, Dmitry, An, Qi, Lau, Audrey, Da, Ben, Flaherty, John, Mercier, Renee-Claude, Zeuzem, Stefan, Cornberg, Markus, Buti, Maria, Aleman, Soo
المصدر: Clinical Hepatology ; page A259.1-A259
بيانات النشر: BMJ Publishing Group Ltd and British Society of Gastroenterology
سنة النشر: 2024
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/gutjnl-2024-iddf.193
DOI: 10.1136/gutjnl-2024-IDDF.193
الاتاحة: http://dx.doi.org/10.1136/gutjnl-2024-iddf.193
https://syndication.highwire.org/content/doi/10.1136/gutjnl-2024-IDDF.193
رقم الانضمام: edsbas.23D383C0
قاعدة البيانات: BASE
الوصف
DOI:10.1136/gutjnl-2024-iddf.193